Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

StageZero Life Sciences Ltd. Regulatory Filings 2022

Mar 18, 2022

44586_rns_2022-03-18_2b8e3822-e0b0-46fe-8833-ccfdadbad383.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [152 x 58] intentionally omitted <==

TSX TRUST COMPANY

VIA ELECTRONIC TRANSMISSION

March 18, 2022

TO ALL APPLICABLE EXCHANGES AND COMMISSIONS:

RE: STAGEZERO LIFE SCIENCES LTD. Confirmation of Notice of Record and Meeting Dates

We are pleased to confirm that Notice of Record and Meeting Dates was sent to The Canadian Depository for Securities.

We advise the following with respect to the upcoming Special Meeting of Security Holders for the subject issuer:

1 ISIN: CA8525403017
CUSIP: 852540301
2 Date Fixed for the Meeting: May 9, 2022
3 Record Date for Notice: March 29, 2022
4 Record Date for Voting: March 29, 2022
5 Beneficial Ownership Determination Date: March 29, 2022
6 Classes or Series of Securities that entitle COMMON
the holder to receive Notice of the Meeting:
7 Classes or Series of Securities that entitle COMMON
the holder to vote at the meeting:
8 Business to be conducted at the meeting: Special
9 Notice-and-Access:
Registered Shareholders: YES
Beneficial Holders: YES
Stratification Level: Not Applicable
10 Reporting issuer is sending proxy-related materials
directly to Non-Objecting Beneficial Owners: YES
11 Issuer paying for delivery to Objecting Beneficial Owners: YES

Yours truly, TSX Trust Company

VANCOUVER CALGARY

650 West Georgia Street, Suite 2700 Vancouver, BC V6B 4N9

300-5th Avenue SW, 10th floor Calgary, AB T2P 3C4

T 604 689-3334

TORONTO

301 - 100 Adelaide Street West Toronto ON M5H 4H1

Toll Free 1-866-600-5869 T 416 361-0930

MONTRÉAL

1800 - 1190, avenue des Canadiens-de-Montréal, C. P. 37 Montréal (Québec) H3B 0G7

T 514 395-5964

T 403 218-2800